Concepedia

Author

M. G. Sarngadharan

National Cancer Institute

Also Known As

M G Sarngadharan, M SARNGADHARAN, M Sarngadharan, M. G. SARNGADHARAN, M. G. Sarngadharan, M.G. SARNGADHARAN, M.G. Sarngadharan, MANGALASSERIL G. SARNGADHARAN, Mangalasseril G Sarngadharan, Mangalasseril G. Sarngadharan

76

Publications

2.9K

Citations

25

H-Index

71

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthBionetics (United States)BioScience Laboratories (United States)Advanced Bioscience Laboratories (United States)
MG

About

M. G. Sarngadharan is an author at National Cancer Institute specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

24

1.6K

2

Natural Sciences

11

11

453

3

Health Sciences

2

2

53

4

Social Sciences

2

2

216

5

Engineering

1

1

37

M. G. Sarngadharan

×

38

Publications

2.5K

Citations

24

H-Index

YearCitations

Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV

Fulvia Veronese, Terry D. Copeland, Anthony L. DeVico,

Science

1986

543

Identification of a Major Growth Factor for AIDS-Kaposi's Sarcoma Cells as Oncostatin M

Bala C. Nair, Anthony L. DeVico, Shuji Nakamura,

Science

1992

222

Reverse Transcriptase Activity of Human Acute Leukaemic Cells: Purification of the Enzyme, Response to AMV 70S RNA, and Characterization of the DNA Product

M. G. Sarngadharan, Prem S. Sarin, Marvin S. Reitz,

Nature New Biology

1972

187

Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.

David A. Cooney, Neil R. Hartman, Carlo Federico Perno,

Molecular Pharmacology

1988

160

Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.

Mads Melbye, Robert J. Biggar, Peter Ebbesen,

BMJ

1984

152

Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus

Stephen Oroszlan, M. G. Sarngadharan, Terry D. Copeland,

Proceedings of the National Academy of Sciences

1982

140

Concomitant Infection with HTLV-I and HTLV-III in a Patient with T8 Lymphoproliferative Disease

Mary‐Ellen Harper, Mark H. Kaplan, Lisa M. Marselle,

New England Journal of Medicine

1986

91

Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro

Christian Stein, Ranajit Pal, Anthony L. DeVico,

Biochemistry

1991

83

Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean.

Jörg Schüpbach, V. S. Kalyanaraman, M. G. Sarngadharan,

PubMed

1983

80

Complete amino acid sequence of human T‐cell leukemia virus structural protein p15

Terry D. Copeland, Stephen Oroszlan, V. S. Kalyanaraman,

FEBS Letters

1983

76

Page 1